Integrates pharmacologic knowledge and clinical decision-making to manage pulmonary disease states and support tobacco cessation through evidence-based practices.
Recent recorded grades — Fall 2022: 4.00 GPA, 100.0% A/AB (n=7 letter grades); Spring 2023: 4.00 GPA, 100.0% A/AB (n=8 letter grades); Spring 2024: 4.00 GPA, 100.0% A/AB (n=7 letter grades).